We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mirati Therapeutics Inc | NASDAQ:MRTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.70 | 58.90 | 58.70 | 0 | 01:00:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-35921
|
|
46-2693615
|
(State of incorporation)
|
|
(Commission File No.)
|
|
(IRS Employer Identification No.)
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
MRTX
|
The NASDAQ Global Select Market
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
Name
|
|
Votes For
|
|
Votes Withheld
|
|
Broker Non-Votes
|
||||||
Charles M. Baum, M.D., Ph.D.
|
|
27,974,448
|
|
|
|
642,976
|
|
|
|
2,035,119
|
|
|
Bruce L.A. Carter, Ph.D.
|
|
25,890,939
|
|
|
|
2,726,485
|
|
|
|
2,035,119
|
|
|
Aaron I. Davis
|
|
28,031,577
|
|
|
|
585,847
|
|
|
|
2,035,119
|
|
|
Henry J. Fuchs, M.D.
|
|
24,321,648
|
|
|
|
4,295,776
|
|
|
|
2,035,119
|
|
|
Michael Grey
|
|
27,313,332
|
|
|
|
1,304,092
|
|
|
|
2,035,119
|
|
|
Faheem Hasnain
|
|
27,739,794
|
|
|
|
877,630
|
|
|
|
2,035,119
|
|
|
Craig Johnson
|
|
25,701,069
|
|
|
|
2,916,355
|
|
|
|
2,035,119
|
|
|
Maya Martinez-Davis
|
|
28,117,639
|
|
|
|
499,785
|
|
|
|
2,035,119
|
|
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
||||||||
28,002,283
|
|
|
172,286
|
|
|
442,855
|
|
|
2,035,119
|
|
|
1 Year
|
|
2 Years
|
|
3 Years
|
|
Abstentions
|
|
Broker Non-Votes
|
|
|||||
28,081,703
|
|
|
22,429
|
|
|
70,648
|
|
|
442,644
|
|
|
2,035,119
|
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
|||||
29,450,907
|
|
|
760,211
|
|
|
441,425
|
|
|
—
|
|
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
||||||||
21,814,030
|
|
|
6,360,370
|
|
|
443,024
|
|
|
2,035,119
|
|
|
Item 9.01
|
Financial Statements and Exhibits
|
|
|
|
|
Date: May 15, 2019
|
|
Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
By:
|
/s/ Jamie A. Donadio
|
|
|
|
Jamie A. Donadio
|
|
|
|
Senior Vice President and Chief Financial Officer
|
1 Year Mirati Therapeutics Chart |
1 Month Mirati Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions